Los Alamos National Laboratory

Los Alamos National Laboratory

Delivering science and technology to protect our nation and promote world stability

Impact of Nuclear Medicine on Emergency Response

Feb 26, 2016 6:00 PM - 8:00 PM
Courtyard Marriott, Santa Fe
Evelyn Mullen
(505) 665-7576

Event Description

A number of novel isotopes and associated drug compounds are being developed, both in the US and elsewhere, for diagnosis and therapy in the field of nuclear medicine.

The accelerator at Los Alamos is one of the locations producing such products. Because not all countries address clinical use approvals in the same way and in the same timeframe, medical tourism has become more common for seeking out the latest regimens where they have been approved for clinical use. Such activity can have unintended and potentially disruptive consequences, since patients returning to the US after such nuclear medicine regimens in another country can set off portal monitors and other detectors in the homeland security arena. Some of these therapeutic isotopes can initially appear to be items of security concern before the US Radiological Triage Program makes an assessment.

We will hear from both the production side (from Dr. Eva Birnbaum, Program Manager, Isotope Production and Distribution Program, Science Program Office, LANL) and the security screening side (from Dr. David Mercer, Radiological Triage Program, Physical Chemistry and Applied Spectroscopy Group, Chemistry Division, LANL) in dual presentations at this dinner meeting.

American Nuclear Society Trinity Section and Rio Grande Health Physics Society Joint Dinner Meeting. More information is available online.